Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTo be prescribed Mounjaro (tirzepatide) for weight management in the UK, you generally need a BMI of 30 or above, or a BMI of 27 or above if you have at least one weight-related health condition such as high blood pressure, type 2 diabetes or high cholesterol. BMI is the starting point, not the whole story — a prescriber assesses your full health picture before any prescription is issued. Mounjaro is a prescription-only medicine, which means a clinician must determine suitability; the number on a BMI calculator gets you to the consultation, not past it. If you want to run your figures before reading on, the NHS BMI calculator takes about forty seconds.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro Summary of Product Characteristics (SmPC), available on the electronic Medicines Compendium, sets out two routes to eligibility. The first is a BMI of 30 or above (the clinical definition of obesity) with no additional conditions required. The second is a BMI between 27 and 29.9, provided you have at least one weight-related comorbidity. The conditions that count include type 2 diabetes, high blood pressure, dyslipidaemia, obstructive sleep apnoea and osteoarthritis, among others.
These thresholds apply to private prescribing. If you are wondering what BMI you need to get Mounjaro through the NHS, the bar is considerably higher, currently a BMI of 40 or above plus four or more specified health conditions, under the phased NHS England rollout. Most people asking this question are looking at the private route, and that is what the rest of this page covers.
One practical check worth doing before a consultation: the NHS BMI tool uses your height and weight and gives you the figure in under a minute. Write it down. Our prescribers will verify it on video as part of the clinical assessment anyway, but knowing your number beforehand means the consultation moves faster.
If your BMI sits just below 27, Mounjaro is not currently licensed for you regardless of other factors. The prescriber cannot override the licensed indication.
Reaching the BMI threshold opens the door to a clinical assessment, it does not guarantee a prescription. A GPhC-registered Independent Prescriber at our clinical team reviews your full consultation before any decision is made.
The things they look at include your medical history (in particular any history of pancreatitis, medullary thyroid carcinoma or multiple endocrine neoplasia type 2, which are contraindications), your current medicines, and whether you are pregnant, breastfeeding or planning to conceive. Mounjaro is not recommended during pregnancy or breastfeeding, and it is not licensed for anyone under 18. If you take an oral contraceptive, the prescriber will discuss adding a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, since tirzepatide can reduce pill absorption, an interaction detail that catches many people by surprise.
For patients transferring from another provider or requesting a dose increase, our prescribers ask for evidence of current treatment and recent weight progress. That is standard clinical practice, not extra bureaucracy. You can read more about what qualifies you for Mounjaro beyond BMI if you want the fuller picture.
NICE's appraisal of tirzepatide (TA1026, published December 2024) formally recommends applying BMI thresholds that are 2.5 kg/m² lower for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean backgrounds. This reflects the clinical evidence that these groups carry a higher health risk at equivalent BMI readings.
In practical terms, what your BMI needs to be for Mounjaro shifts so that the 30 threshold becomes 27.5, and the 27 threshold for people with comorbidities becomes 24.5. These adjustments are part of UK clinical guidance, not a pharmacy-by-pharmacy policy choice. If you are unsure whether the adjustment applies to you, it is exactly the kind of question to raise in a consultation rather than try to self-determine from a webpage.
Private prescribing follows the licensed SmPC indications and UK clinical guidance; the ethnic-background adjustment is part of that guidance and is applied in clinical assessment. If cost is a consideration alongside eligibility, the Mounjaro cost context page breaks down what private treatment pricing actually includes.
If you meet the BMI criteria and have no contraindications, the process through a regulated UK pharmacy is straightforward. At nume, a free consultation is reviewed the same day by a real prescriber, a named clinician reads your answers, not software. Identity is verified with photo ID, and weight is confirmed on a short video call. If you are clinically suitable and your order is placed before noon on a working day, your treatment is dispatched the same day and arrives with DPD the next working day in plain packaging.
Treatment starts at the 2.5 mg dose regardless of your BMI or weight, and if you want to understand what BMI you have to be for Mounjaro before booking, that page covers the criteria in full. The first pen's purpose is to let your body adjust to the medicine, not to produce weight loss immediately. Titration is managed by the prescriber over subsequent months. Every repeat order at our Mounjaro service involves a fresh clinical review; there are no automatic renewals.
For a broader look at what Mounjaro involves before you decide, the weight-loss treatment overview covers the landscape. When you are ready, start your free consultation and a prescriber will assess your suitability the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.